Micro-cap drug developer Vallon Pharmaceuticals sets terms for $15 million IPO

Vallon Pharmaceuticals, a biopharma developing abuse-deterrent prescription drugs for CNS disorders, announced terms for its IPO on Thursday. The Philadelphia, PA-based company plans to raise $15 million by offering 1.7 million shares at a price range of $8 to $10. At the midpoi

source https://www.nasdaq.com/articles/micro-cap-drug-developer-vallon-pharmaceuticals-sets-terms-for-%2415-million-ipo-2021-01-14